Traditionally, α-smooth muscle actin (α-SMA) was identified as a marker of active CAFs and a prognostic factor in tumor patients; however, certain subtypes of CAFs are characterized by a far lower degree of α-SMA (176, 179, 180). This evidence concerns the gene ACTA1 and neoplasm.